These names are showing technical characteristics of either bullish or bearish reversal patterns.
Jim Cramer doesn't buy the backlash against Amazon. He says Prime is a very powerful tool and an irresistible bargain.
Jim Cramer is bullish on Citigroup, Zoetis, Idexx Labs, AbbVie, Nucor, and Alexion.
Banks that find themselves on the cusp of certain regulatory thresholds could be big winners under the Trump Treasury Department.
The Federal Reserve is raising to $100 billion the amount of combined assets that would trigger a systemic risk review of proposed bank mergers.